{"disease":{"id":"afp-gastric-or-gastroesophageal-junction-adenocarcinoma","name":"afp gastric or gastroesophageal junction adenocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07515625","title":"Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":46,"lead_sponsor_name":"Fudan University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}